Proceedings of the Royal Society of Medicne 1U [February 14, 1933.] DISCUSSION ON THE USE OF IODINE COMPOUNDS IN THE TREATMENT OF THYROID DISEASE. Professor C. R. Harington: (Historical aspect). The use of iodine in disorders of the thyroid, particularly in Graves' disease, is a subject about which there is considerable discussion and concerning which widely divergent views are held. I think, therefore, that it may be profitable to consider the factors responsible for the development of this method of treatment and further to consider those chemical and physiological properties of the thyroid which have a direct bearing on the problem and which may enable us to reach a theoretical conclusion concerning the soundness or otherwise of the treatment adopted.
In the first place I should like to say something about simple goitre, since although the successful solution of the problem of the prophylaxis of this disease is now a matter of common knowledge, there can be few cases which afford a clearer illustrationi of the development of a method of treatment from empiricism to a securely established scientific therapy.
It is said that a soup made from seaweed was employed by the Chinese in the treatment of goitre many centuries B.C. Of the authority for this statement I am not certain; the earliest reference bearing on the present discussion which I have myself been able to trace is contained in the writings of Arnaldus Villanovanus (thirteenth century, A.D.); this author discusses the medical treatment of goitre at some length and proposes as a specific remedy a preparation containing, among other constituents, burnt sponge and seaweed. A similar prescription, evidently derived from that of Arnaldus, appears in the Philonium Cheirurgicum of Valescus de Taranta (1418), and again, in 1698, we find Musitanus recommending burnt sponge as a specific for enlargement of the thyroid. The prescription of the last-named author is much simpler in character than those of Arnaldus and Valescus; it is clear that he recognized the burnt sponge to be the essential active constituent and he even goes so far as to describe as "praejudicium vulgi" the requirement insisted upon by his predecessors that the remedy must be taken during the wane of the moon.
The use of burnt sponge in the treatment of goitre does not seem to have been taken up in this country until the middle of the eighteenth century when it appears in a curious manner as the " Coventry Treatment " for goitre. The nature of this treatment remained a secret in the possession of a family at Coventry for many years before it was finally divulged to a Dr. Wilmer who published a full account of it in 1779. The prescription given by Wilmer is an almost literal translation of that of Musitanus; it is amusing to note, however, that Wilmer was not so free from the " praejudicium vulgi" as his predecessor, for he includes the requirement that the remedy shall be taken during the wane of the moon and naively concludes " Some parts of these directions seem to bear the character of empiricism; but where no harm can possibly arise from, nor inconvenience follow their use, it is to be wished that those who think proper to give the preceding method a trial, will do so in the manner recommended."
Wilmer's account of the " Coventry Practice " found its way almost verbatim into Parr's London Medical Dictionary (1809) and the burnt sponge remedy was accepted by Foder& (1800) as a true specific in the treatment of goitre; it was evidently generally regarded at this period as a valuable, if empirical, remedy for the disease, the only objection to its use being its liability to cause gastric disturbances. The next line of evidence pointing to the essential importance of iodine in the economy of the thyroid was provided by the work of Chatin from 1850-1854, which demonstrated quite clearly a direct correlation between the occurrence of endemic goitre and environmental deficiency of iodine. The almost universal scepticism with which the important results of Chatin were regarded, however, prevented his discovery, for the time at least, from bringing about a notable advance in understanding of the thyroid problem; it was not until some seventy years later that Chatin's theory was vindicated by the work of such investigators as McClendon in America, von Fellenberg in Switzerland, and Hercus, Benson and Carter in New Zealand, with the result that now the adoption of iodine prophylaxis for endemic goitre is meeting with universal success.
Before the end of the last century, however, two fundamental observations were made which provided a logical justification for many of the results of the earlier workers; these were the demonstration by Murray in 1891 that the thyroid actually secreted an active principle which could be employed in replacement therapy where normal thyroid function had been lost, and the discovery by Baumann in 1895 that iodine was a normal constituent of the thyroid gland itself and was apparently associated with the physiological activity of this organ.
The observation of Baumann led, on the one hand, to the extensive chemical investigation of the thyroid which has finally resulted in the isolation of the iodinecontaining active principle and to its identification and synthesis, and on the other to the morphological-chemical studies of Marine which have a direct bearing on iodine therapy.
It had early been observed that the iodine content of thyroid glands showed variations under pathological conditions, running, in general, parallel with the colloid content, so that a parenchymatous goitre containing little or no colloid might be almost free from iodine, whilst a colloid goitre might contain very large quantities. Marine's essential contribution consisted in the correlation of these observations upon a basis of concentration rather than total content of iodine, for he was able to show that the least departure from the normal structure of the gland in the direction of glandular hyperplasia was accompanied by a marked fall in the iodine concentration; in general, iodine concentration was inversely proportional to the degree of glandular hyperplasia. Conversely, restriction of exogenous iodine could be used as an experimental means of inducing a hyperplasia of the thyroid, entirely analogous to that elicited by sub-total thyroidectomy, whilst administration of iodine would prevent the development of thyroid hyperplasia under these conditions and would bring about involution of an existing hyperplasia. These observations seem to me to afford the only reasonable basis for a consideration of iodine therapy in Graves' disease.
From the time when it was first recognized that Graves' disease was associated with pathological change in the thyroid, iodine was tried from time to time as a remedy, on the basis of the success which had been met with in its use in simple goitre, Although isolated good results were obtained-as for instance in the frequently quoted case in which Trousseau prescribed iodine accidentally-the majority of workers on Graves' disease reported unfavourably regarding iodine therapy, a conclusion which seemed eminently reasonable on the assumption that the symptoms of the disease were caused by over-production of an iodine-containing active principle. This view was urged particularly by Kocher, who regarded Graves' disease as being due to a " thyroid diarrhoea," the active principle being synthesized by the gland at a rapid rate and immediately released. Kocher moreover emphasized the danger, already realized in the early days of iodine therapy, of precipitating incipient Graves' disease or adenomatous goitre by administration of iodine into a condition of severe hyperthyroidism (" Jod-Basedow ").
There existed, however, another theory of Graves' disease, originated by Mobius in 1896, which regarded the condition as dysthyroidism rather than hyperthyroidism. Reverting to this theory, nearly thirty years later Plummer extended it by assuming that the thyroid in Graves' disease produced a toxic secretion which owed its abnormality to deficiency of iodine. On this assumption is based the method of intensive iodine therapy in Graves' disease advocated by Plummer and now widely practised. The discussion of the details of this therapy I must leave to subsequent speakers but I wish to emphasize that the direct study of derivatives of thyroxine, particularly of those deficient in iodine, has afforded no justification for the assumption on which it is based and that the correctness of this assumption is in any case denied by the limited period during which iodine therapy exercises its good effect.
Moreover, if we consider the morphological reaction of the thyroid in Graves' disease to administration of iodine, we find that it conforms to the general rules laid down by Marine. The thyroid in Graves' disease usually shows a high degree of glandular hyperplasia; it contains little colloid and little iodine. The response to iodine therapy consists in rapid involution of the hyperplasia with storage of colloid and of iodine, and it is only during this period of involution that the remission of symptoms appears to persist.
Furthermore, the argument in favour of the dysthyroidism theory-which is based on the failure or positively harmful effect of iodine therspy in adenomatous goitre-is fallacious, since it has been quite clearly shown by Marine that adenomata of the thyroid, whilst they must be regarded as representing functioning thyroid tissue, are distinguished by the fact that they do not respond to variations in the iodine supply in the manner characteristic of the ordinary gland tissue.
I am therefore of the opinion that the " thyroid diarrhoea " suggestion of Kocher expresses the truth of the matter and that the temporary good effect of iodine therapy in Graves' disease is to be explained on some such lines as those suggested by Marine, namely, by a temporary arrest of this "diarrhoea " owing to pressure retention of the secretion during the period when the structural elements of the gland are adjusting themselves to the rapid involution. The cause of the "thyroid diarrhoea" is, I believe, to be sought outside the thyroid gland itself, possibly in the release of a control normally exercised by the suprarenal cortex or in an interaction of the pituitary with the thyroid.
If we accept such a hypothesis, we must admit that iodine therapy in Graves' disease cannot, any more than the surgical treatment with which it is frequently reinforced, claim to be more than a palliative measure which will only hold its own so long as we remain in ignorance of the real cause of the malady.
As a palliative or pre-operative treatment iodine therapy is, however, at present of unquestionable importance, and I should like to conclude with a practical suggestion, the only one which I am able to make, concerning the most suitable mode of administration of the iodine. The constitution of thyroxine, and the fact that this compound occurs in the thyroid together with diiodotyrosine, makes it almost certain that the biological synthesis of thyroxine takes place from tyrosine through the stage of diiodotyrosine and also that the latter is an essential constituent of colloid. Now if we accept the view, mentioned already, that pressure retention 13 873 of the secretion is the mechanism through which iodine exercises its temporary good effect, it is evidently desirable that the action of the iodine should be elicited as rapidly as possible. Attempts to achieve this object by the massive administration of elementary iodine or iodides are open to the objection of the risk of producing. iodism; this risk can be avoided and at the same time the processes to which the iodine must be subjected in the body can be shortened by one stage if the iodine be given in the form of diiodotyrosine. Some promising experiments in this direction have already been made and I suggest that the method is worthy of a more extended trial. Dr. H. Gardiner-Hill (Clinical Aspect): A discussion on iodine in relation to thyroid disease from the clinical aspect really amounts to a consideration of the value of iodine in the treatment of simple goitre and toxic goitre. Most clinicians would, I fancy, agree that iodine plays little or no part in the treatment of cretinism or myxcedema, or, for that matter, of frank hypothyroidism, even when it develops in an individual who has had a long-standing simple goitre. The treatment for these conditions is thyroid extract, a therapeutic measure which does not quite come within the scope of this discussion. I shall therefore confine myself to the problems of iodine in the treatment of simple and toxic goitre.
Iodine as a therapeutic measure in simple goitre.-Professor Harington has given you an account of early therapeutic experiences with iodine in simple goitre, and of the various theories on which this treatment was based. He has described the views of Marine, who regards simple goitre as a compensatory hyperplasia, or work hypertrophy, of the thyroid for absolute or relative lack of iodine. Some authorities, as you know, are of the opinion that iodine is not the only factor; McCarrison, for instance, has put forward his views about the relation of goitre to dietetic deficiency.
Most of the simple goitres which we are called upon to treat in London are of the sporadic variety. Perhaps in about 10% of cases the goitre originated in an endemic area and subsequently the individual migrated. A review of my own cases shows that a very large proportion of sporadic simple goitres develop during the period of puberty and maximum growth, or during pregnancy and lactation, or at the climacteric. In others the condition has arisen after an infective illness. These are data which, I think, can be very well accounted for on Marine's theory.
Before passing on to the clinical and therapeutic aspects of the iodine problem, there is one recent paper which I should like 'to mention which shows the importance of systemic infections and their capacity to produce changes in the thyroid gland. Womack and Cole found, a few years ago, that very definite chemical, as well as histological, changes could be demonstrated in the thyroid after infections. These changes were enlargement of the gland macroscopically, and microscopically desquamation and death of many of the acinous cells, with loss of colloid and hyperplasia of many of the remaining cells. Chemically, the iodine content per gramme of tissue was much reduced. In a second and recent paper they showed that experimental infections in animals produced similar changes in the thyroid, which were associated with a rise in basal metabolism. Iodine feeding prevented these changes and lowered the basal metabolism. This work, though it needs confirmation, has, I think, an important bearing on our discussion.
I the dosage of iodine was increased. They report a fall in the basal metabolic rate at each augmentation of the dose in 76% of cases. With the fall in metabolism they describe an improvement in the clinical signs. In their paper they mention patients under observation and treatment by this method for as long as three years. In these patients they say that they hope it will not be necessary to operate, a method of expression which rather suggests to my mind that the thyrotoxtmia had not been entirely controlled. The majority of clinicians in this country would be less optimistic as to the value of iodine as a routine measure, though several have expressed the opinion that if it is given the disease runs its course at a somewhat lower level of intoxication. This is the view which would fit in best with my experience. With medical treatment alone, however, and especially with iodine, there always appears to be a tendency for primary Graves' disease to relapse on the least provocation, usually anxiety or some infective illness, and the results of medical treatment are not comparable to those obtained with operative measures. Unfortunately in certain cases mental and other considerations are so predominant that operation does not appear to be a justifiable risk.
We shall probably all agree as to the immediate beneficial effects of iodine in primary Graves' disease. There is usually a striking subjective and objective improvement during the first fortnight after iodine treatment has been instituted. The basal metabolic rate falls to a level often below the normal, the pulse-rate slows and the body-weight, previously declining, begins to rise. The most striking effects occur in the thyroid gland itself. Whereas before treatment the gland is usually soft, pulsating and vascular, judged by the bruit which one hears over it with a stethoscope, after a few days it hardens up and the vascularity is considerably diminished. Histological sections at this stage will show a return of colloid in the vesicles. This beneficial immediate reaction to iodine we should now generally agree is best taken advantage of as a preliminary to operative measures. Not all cases of primary Graves' disease respond immediately in this satisfactory way. The cases which benefit most are generally those with large previously uniodized vascular goitres. This is usually the type of gland in the younger patients. These glands appear to me to harden up to the maximum extent after iodization. In the older patients who develop primary Graves' disease, especially those about the time of the climacteric, the initial thyroid swelling uniodized is often small and fewer signs of vascularity can be detected. These glands do not seem to me to harden up in the same way nor is the immediate beneficial iodine remission quite so satisfactory.
(b) Iodine as a therapeutic measure in secondary Graves' disease.-Since Kocher pointed out, about thirty years ago, that colloid goitres with indurated nodules might become thyrotoxic after iodine administration, there has been a tendency to regard this preparation as contra-indicated in secondary Graves' disease. Plummer elaborated this view, and came to the conclusion that iodine had a bad influence in what he described as toxic adenoma, i.e., the type of secondary Graves when it is responsible for the condition, does appear to exert a most beneficial action on the symptoms, and iodine given subsequently generally produces a further improvement in the disease. It is, however, extraordinarily difficult to assess its value as one has no opportunity for control observations. The fact remains that we still treat most of these cases with iodine and believe that they do run a course at a lower level of intoxication than those which are not treated in this way. This diffuse group is an extremely difficult therapeutic problem, for they seem to be resistant to most forms of treatment. Surgical interference, in my experience, almost invariably results in a recurrent hypertrophy of any thyroid tissue which is left in spite of iodine treatment, whilst the symptoms usually continue unabated. Our present plan is to combine iodine therapy with periodic doses of X-rays. a method which has given more satisfactory results than any other.
As regards the effect of iodine in the nodular goitres of secondary Graves' disease, one is on surer ground in expressing an opinion. One bas to give iodine to such patients with more caution, for though some may derive benefit, in others there is a tendency to intolerance. In these cases the initial striking improvement found in primary Graves' disease with iodine is seen less often, but I would always try it and in fact do make a point of doing so as a pre-operative measure. Fortunately, this nodular type of secondary Graves' disease appears to respond satisfactorily to operative treatment, especially if the gland has reached a fibrotic stage when operation is undertaken. Then there does not seem to be the tendency to recurrent hypertrophy such as is found in the diffuse secondary toxic goitres.
It is my impression that the degree to which the gland hardens in Graves' disease is related to the degree of improvement clinically. I mention this in the hope that others will either be able to confirm or refute it. I would also like to consider a possible theoretical explanation of this observation: The most striking effect of iodine on the gland histologically in primary Graves' disease is to fill the depleted vesicles with colloid though the secreting tissue remains as before. The most striking effect of iodine on these glands macroscopically, is to harden them up sometimes to a most remarkable degree. The most striking effect of iodine on the gland surgically is to diminish vascularity. It is, I think, worthy of consideration as to how far these beneficial effects of iodine are due to purely mechanical causes-to distension of the vesicles with colloid, leading to pressure on surrounding blood-vessels and secreting tissue.
Mr. -T. P. Dunhill said that the question of the extent to which iodine should be used in the general treatment of the disease was a somewhat vexed one. Many surgeons would restrict its use to the preparation of a patient for operation. There was much to be said for this view, as he would point out later, but the use of iodine should not be denied to physicians in the early stages of the disease, or in the treatment of a crisis. Physicians, however, should realize its limitations, and give consideration to what might be expected from it later, in preparation for operation. The patient in the early stages of the disease might possibly be restored to equilibrium by its use, combined with other appropriate measures, but it should not be persisted in if it failed to achieve the result expected from it. Speaking from the purely surgical point of view, it must be remembered that the exaggerated claims often made for iodine were not voiced by Dr. Plummer. His statement was that many patients were greatly benefited by it, others to a less extent, some no more than they could be by good hospital treatment, while a few were definitely made worse. Some surgeons, with more optimism than truth, had published the statement that with the use of iodine there was no longer any necessity for the ligation of arteries, or for operation to be carried out in stages. This was not his (the speaker's) experience. Many patients still came for operation who were desperately ill, and some of these failed to respond in the slightest degree to the administration of iodine. Possibly this was because it had already been given for a long period in large doses, and the capacity of the patient to respond to it had thus been lost. In such cases the operation remained a very grave one, and a subtotal thyroidectomy in one stage could not be made safe for patients who were so ill. He had lost two patients in the last two or three years even though he had begun by ligation of arteries, and had later dealt with one lobe at a time. These deaths might have been due to the misuse of iodine in the earlier stages of treatment. It was more than likely that they could have been operated upon without risk if the operation had been performed during that first response to iodine. It was when a surgeon had to deal with-and occasionally lose in spite of graded operations-these extremely ill patients, that he felt strongly about the indiscriminate administration of iodine in the earlier stages of the disease.
The number of these severely ill patients was surprising. It would be thought from the claims made for medical treatment, elimination of sepsis, or X-ray treatment, that they would become fewer and tend to disappear. On the contrary the numbers appeared to be increasing. Was this because of the lack of supervision in the employment of iodine, or simply because iodine had failed to control the disease ? Physicians should surely bear these facts in mind.
With regard to the question raised by the two openers as to the value of iodine in nodular goitre with toxic symptoms: It had a definite value, but the amounts given should be less than in a case of primary toxic goitre. He (Mr. Dunhill) believed that the iodine required would be found to bear a relationship to the amount and condition of the functioning thyroid epithelium.
